Excitement is building however even some of the most optimistic...

Excitement is building however even some of the most optimistic machinations barely scratch the surface of CF33’s potential. Apart from cancer killing IMU may have a safe platform for delivering ANY protein in managed doses. If it’s accepted that CF33 infects healthy cells as well but only replicates in cancer cells, it ‘s not too far a moon shot to insert a gene that’s an early expression gene (on infection) before replication genes are expressed. The early protein would be translated but no lysis would occur. What about CF33 + human insulin gene for example. In short, CF33 could trump mRNA technology. I think it’s important to consider the value of an asset is not just what’s at face value but its potential. Just optimistic ramblings high on Easter eggs, not financial advice.